Canonsburg, Pa.-based Mylan will pay $96.5 million to settle a class-action lawsuit alleging it entered a “pay-to-delay” deal with the drugmaker Cephalon, reports Bloomberg. The lawsuit, filed by a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results